mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.06 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |